Human mitochondrial aldehyde dehydrogenase (ALDH-I) is potently, reversibly, and selectively inhibited by an isoflavone isolated from Radirpuerariac and identified as daidzin, the 7-glucoside of 4',7-dihydroxyisoflavone. Kinetic analysis with formaldehyde as substrate reveals that daidzin inhibits ALDH-I competitively with respect to formaldehyde with a K1 of 40 nM, and uncompetitively with respect to the coenzyme NAD+. The human cytosolic aldehyde dehydrogenase isozyme (ALDH-II) is nearly 3 orders of magnitude less sensitive to daidzin inhibition. Daidzin does not inhibit human class 1,1, or JI alcohol dehydrogenases, nor does it have any significant effect on biological systems that are known to be affected by other isoflavones. Among more than 40 structurally related compounds surveyed, 12 inhibit ALDH-I, but only prunetin and 5-hydroxydaidzin (genistin) combine high selectivity and potency, although they are 7-to 15-fold less potent than daidzin. Structure-function relationships have established a basis for the design and synthesis of additional ALDH inhibitors that could both be yet more potent and specific.The NAD+-dependent aldehyde dehydrogenase (ALDH) catalyzes the oxidation of acetaldehyde, the primary product of ethanol metabolism, and a wide spectrum of other aldehyde metabolites including biogenic amines such as dopamine, serotonin, and norepinephrine (1). Human liver contains at least four ALDH isozymes, but their physiological roles in the metabolism of specific aldehydes are still not defined completely (1, 2). The two most abundant ALDH isozymes found in human liver are ALDH-I in mitochondria and ALDH-II in the cytosol. Ofthese, the affinity of acetaldehyde for ALDH-I is much greater than that for ALDH-II (1, 2) and hence, ALDH-I is thought to be the one principally responsible for the detoxification of acetaldehyde. This is confirmed by the fact that in 50%o' of Asians, liver ALDH-I is present as a catalytically inactive genetic variant of this enzyme (2). The capacity of individuals with this trait to metabolize acetaldehyde is markedly impaired (3) as signaled by facial flushing soon after ingestion of ethanol (4). Interestingly, alcoholism and alcohol abuse are virtually nonexistent among this Asian population (1,5). The absence of ALDH-I activity in these individuals is not known to generate any other deleterious metabolic consequences. Such findings suggest the use of a specific inhibitor of this enzyme as an approach to the treatment of alcohol abuse in a population with the active form of ALDH-I.While disulfiram (Antabuse) is an ALDH inhibitor, it primarily inhibits ALDH-II and does so by covalently modifying sulfhydryl groups (6). More importantly, it is nonspecific and also covalently modifies the catalytically essential sulfhydryl groups of many other physiologically important enzymes, thereby irreversibly inactivating some that are crucial to neurotransmitter metabolism (dopamine 3-hydroxylase), drug metabolism and detoxification (microsomal mixed-function oxidases), and mult...